beta
KALA
Kala Bio Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala’s website at www.kalarx.com.
Market Cap: 20.2 Million
Primary Exchange: NASDAQ
Website: http://kalarx.com/
Shares Outstanding: 2.69 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.8931359256393115
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Ethical Flags
Longest drawdown: 1780 trading days
From: 2017-09-14 To: 2022-12-29
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|---|---|---|---|---|---|---|---|
| 2022-08-26 | 2022-08-30 | 2022-08-29 | 2022-08-18 | 0.0 | Stock |
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|